Protagonist Therapeutics (PTGX) Total Current Liabilities (2017 - 2025)
Historic Total Current Liabilities for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $44.9 million.
- Protagonist Therapeutics' Total Current Liabilities rose 81.65% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.9 million, marking a year-over-year increase of 81.65%. This contributed to the annual value of $47.4 million for FY2024, which is 12279.78% up from last year.
- Protagonist Therapeutics' Total Current Liabilities amounted to $44.9 million in Q3 2025, which was up 81.65% from $35.5 million recorded in Q2 2025.
- In the past 5 years, Protagonist Therapeutics' Total Current Liabilities registered a high of $47.4 million during Q4 2024, and its lowest value of $21.3 million during Q4 2023.
- In the last 5 years, Protagonist Therapeutics' Total Current Liabilities had a median value of $39.2 million in 2021 and averaged $36.8 million.
- Per our database at Business Quant, Protagonist Therapeutics' Total Current Liabilities plummeted by 4654.59% in 2023 and then surged by 12279.78% in 2024.
- Protagonist Therapeutics' Total Current Liabilities (Quarter) stood at $44.0 million in 2021, then decreased by 29.16% to $31.2 million in 2022, then tumbled by 31.77% to $21.3 million in 2023, then surged by 122.8% to $47.4 million in 2024, then decreased by 5.18% to $44.9 million in 2025.
- Its Total Current Liabilities stands at $44.9 million for Q3 2025, versus $35.5 million for Q2 2025 and $35.1 million for Q1 2025.